Inter Pharma PCL (BKK:IP)
Thailand · Delayed Price · Currency is THB 4.980
0.00 (0.00%)
Sep 3, 2026, 4:36 PM ICT
Inter Pharma PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,243 | 2,193 | 1,897 | 1,781 | 1,523 | 908.63 |
Other Revenue | 16.14 | 20.57 | 14.62 | 17.54 | 11.12 | 12.35 |
| 2,259 | 2,214 | 1,912 | 1,799 | 1,534 | 920.98 | |
Revenue Growth | 10.15% | 15.80% | 6.29% | 17.23% | 66.61% | 106.07% |
Cost of Revenue | 1,291 | 1,293 | 1,188 | 1,122 | 905.42 | 507.85 |
Gross Profit | 968.5 | 920.76 | 724.36 | 676.98 | 629.03 | 413.14 |
Selling, General & Admin | 751.81 | 728.78 | 650.14 | 567.58 | 458.23 | 267.36 |
Operating Expenses | 751.81 | 728.78 | 650.14 | 567.58 | 458.23 | 267.36 |
Operating Income | 216.69 | 191.97 | 74.22 | 109.4 | 170.8 | 145.77 |
Interest Expense | -17.15 | -19.58 | -19.85 | -25.76 | -23.34 | -8.01 |
Earnings From Equity Investments | -1.2 | -1.23 | -1.59 | -2.27 | -0.77 | -0.08 |
EBT Excluding Unusual Items | 198.34 | 171.17 | 52.78 | 81.37 | 146.69 | 137.68 |
Pretax Income | 198.34 | 171.17 | 52.78 | 81.37 | 146.69 | 137.68 |
Income Tax Expense | 42.61 | 35.1 | 16.16 | 22.47 | 19.41 | 27.2 |
Earnings From Continuing Operations | 155.73 | 136.07 | 36.63 | 58.9 | 127.29 | 110.48 |
Minority Interest in Earnings | -17.75 | -13.69 | 0.02 | -8.11 | -8.4 | -5.27 |
Net Income | 137.98 | 122.38 | 36.65 | 50.79 | 118.88 | 105.22 |
Net Income to Common | 137.98 | 122.38 | 36.65 | 50.79 | 118.88 | 105.22 |
Net Income Growth | 94.95% | 233.93% | -27.84% | -57.28% | 12.99% | 100.27% |
Shares Outstanding (Basic) | 605 | 605 | 605 | 605 | 532 | 475 |
Shares Outstanding (Diluted) | 605 | 605 | 605 | 605 | 532 | 475 |
Shares Change | - | - | - | 13.78% | 11.97% | 1.05% |
EPS (Basic) | 0.23 | 0.20 | 0.06 | 0.08 | 0.22 | 0.22 |
EPS (Diluted) | 0.23 | 0.20 | 0.06 | 0.08 | 0.22 | 0.22 |
EPS Growth | 94.95% | 233.93% | -27.84% | -62.45% | 0.91% | 98.19% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 113.56 | 167.33 | -59.59 | 14.96 | 115.72 | -265.73 |
Free Cash Flow Per Share | 0.19 | 0.28 | -0.10 | 0.03 | 0.22 | -0.56 |
Dividend Per Share | 0.073 | 0.073 | - | 0.021 | 0.111 | - |
Dividend Growth | - | - | - | -80.69% | 975.73% | - |
Gross Margin | 42.87% | 41.59% | 37.89% | 37.64% | 40.99% | 44.86% |
Operating Margin | 9.59% | 8.67% | 3.88% | 6.08% | 11.13% | 15.83% |
Profit Margin | 6.11% | 5.53% | 1.92% | 2.82% | 7.75% | 11.42% |
Free Cash Flow Margin | 5.03% | 7.56% | -3.12% | 0.83% | 7.54% | -28.85% |
EBITDA | 284.6 | 272.49 | 138.54 | 167.66 | 208.7 | 170.85 |
EBITDA Margin | 12.60% | 12.31% | 7.25% | 9.32% | 13.60% | 18.55% |
D&A For EBITDA | 67.92 | 80.51 | 64.32 | 58.25 | 37.9 | 25.08 |
EBIT | 216.69 | 191.97 | 74.22 | 109.4 | 170.8 | 145.77 |
EBIT Margin | 9.59% | 8.67% | 3.88% | 6.08% | 11.13% | 15.83% |
Effective Tax Rate | 21.48% | 20.50% | 30.61% | 27.61% | 13.23% | 19.75% |
Revenue as Reported | 2,259 | 2,214 | 1,912 | 1,799 | 1,534 | 920.98 |
Advertising Expenses | - | 31.27 | 93.14 | 70.61 | 31.91 | 41.13 |